Cargando…

Brain Changes in Responders vs. Non-Responders in Chronic Migraine: Markers of Disease Reversal

The aim of this study was to identify structural and functional brain changes that accompanied the transition from chronic (CM; ≥15 headache days/month) to episodic (EM; <15 headache days/month) migraine following prophylactic treatment with onabotulinumtoxinA (BoNT-A). Specifically, we examined...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hubbard, Catherine S., Becerra, Lino, Smith, Jonathan H., DeLange, Justin M., Smith, Ryan M., Black, David F., Welker, Kirk M., Burstein, Rami, Cutrer, Fred M., Borsook, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5052273/ https://www.ncbi.nlm.nih.gov/pubmed/27766076 http://dx.doi.org/10.3389/fnhum.2016.00497

Ejemplares similares

Galcanezumab effects on incidence of headache after occurrence of triggers, premonitory symptoms, and aura in responders, non-responders, super-responders, and super non-responders
por: Ashina, Sait, et al.
Publicado: (2023)

Migraine in the Young Brain: Adolescents vs. Young Adults
por: Colon, Elisabeth, et al.
Publicado: (2019)

Altered Hypothalamic Functional Connectivity with Autonomic Circuits and the Locus Coeruleus in Migraine
por: Moulton, Eric A., et al.
Publicado: (2014)

Interictal Dysfunction of a Brainstem Descending Modulatory Center in Migraine Patients
por: Moulton, Eric A., et al.
Publicado: (2008)

Migraine attacks the Basal Ganglia
por: Maleki, Nasim, et al.
Publicado: (2011)

Responsivity of Periaqueductal Gray Connectivity Is Related to Headache Frequency in Episodic Migraine
por: Solstrand Dahlberg, Linda, et al.
Publicado: (2018)

Ictal and interictal brain activation in episodic migraine: Neural basis for extent of allodynia
por: Maleki, Nasim, et al.
Publicado: (2021)

Excitatory neurotransmitters in brain regions in interictal migraine patients
por: Prescot, Andrew, et al.
Publicado: (2009)

Primary Somatosensory Cortices Contain Altered Patterns of Regional Cerebral Blood Flow in the Interictal Phase of Migraine
por: Hodkinson, Duncan J., et al.
Publicado: (2015)

Increased Functional Activation of Limbic Brain Regions during Negative Emotional Processing in Migraine
por: Wilcox, Sophie L., et al.
Publicado: (2016)

Cortico–Cortical Connections of Primary Sensory Areas and Associated Symptoms in Migraine
por: Hodkinson, Duncan J., et al.
Publicado: (2017)

Neurochemical Pathways That Converge on Thalamic Trigeminovascular Neurons: Potential Substrate for Modulation of Migraine by Sleep, Food Intake, Stress and Anxiety
por: Noseda, Rodrigo, et al.
Publicado: (2014)

Defining Responders vs Non-Responders After Total Ankle Arthroplasty
por: Steele, John R., et al.
Publicado: (2019)

A Real‐World Analysis of Patient Characteristics, Treatment Patterns, and Level of Impairment in Patients With Migraine Who are Insufficient Responders vs Responders to Acute Treatment
por: Lombard, Louise, et al.
Publicado: (2020)

OnabotulinumtoxinA in chronic migraine: is the response dose dependent?
por: Zandieh, Ali, et al.
Publicado: (2022)

The Impact of OnabotulinumtoxinA vs. Placebo on Efficacy Outcomes in Headache Day Responder and Nonresponder Patients with Chronic Migraine
por: Silberstein, Stephen D., et al.
Publicado: (2020)

Peripherally acting anti-CGRP monoclonal antibodies alter cortical gray matter thickness in migraine patients: A prospective cohort study
por: Szabo, Edina, et al.
Publicado: (2023)

Characterizing Treatment Non-responders vs. Responders in Completed Alzheimer’s Disease Clinical Trials
por: Wang, Dulin, et al.
Publicado: (2023)

Diffuse Optical Tomography Activation in the Somatosensory Cortex: Specific Activation by Painful vs. Non-Painful Thermal Stimuli
por: Becerra, Lino, et al.
Publicado: (2009)

Hazardous materials for first responders
por: Wieder, Michael A, et al.
Publicado: (1994)

Molecular and functional PET-fMRI measures of placebo analgesia in episodic migraine: Preliminary findings
por: Linnman, Clas, et al.
Publicado: (2017)

A touchy subject: an assessment of cutaneous allodynia in a chronic migraine population
por: Mathew, Paul G, et al.
Publicado: (2016)

Readers Respond
por: Channabasavanna, S. M.
Publicado: (2004)

Breaking down the barriers: fMRI applications in pain, analgesia and analgesics
por: Borsook, David, et al.
Publicado: (2006)

HelpResponder—System for the Security of First Responder Interventions
por: Rodriguez-Sanchez, M. Cristina, et al.
Publicado: (2021)

Efficacy of Ubrogepant in the Acute Treatment of Migraine With Mild Pain vs Moderate or Severe Pain
por: Lipton, Richard B., et al.
Publicado: (2022)

The Authors Respond
por: Sherrill, Christina H., et al.
Publicado: (2020)

A ‘complex’ of brain metabolites distinguish altered chemistry in the cingulate cortex of episodic migraine patients
por: Becerra, L., et al.
Publicado: (2016)

The Authors Respond
por: Miller, Ross M., et al.
Publicado: (2012)

The Authors Respond
por: Traini, Eugenio, et al.
Publicado: (2022)

To respond or not to respond: exploring empathy-related psychological and structural brain differences between placebo analgesia responders and non-responders
por: Hartmann, Helena, et al.
Publicado: (2023)

Case reports on two patients with episodic vertigo, fluctuating hearing loss and migraine responding to prophylactic drugs for migraine. Menière’s disease or migraine-associated vertigo?
por: TEGGI, R., et al.
Publicado: (2010)

Respondent
por: Mitchell, Samuel A.
Publicado: (1992)

Clinical evaluation of super-responders vs. non-responders to CGRP(-receptor) monoclonal antibodies: a real-world experience
por: Raffaelli, Bianca, et al.
Publicado: (2023)

Real-World Analysis of Clinical Characteristics, Treatment Patterns, and Patient-Reported Outcomes of Insufficient Responders and Responders to Prescribed Acute Migraine Treatment in China
por: Zhang, Lei, et al.
Publicado: (2023)

Pharmacokinetics of sumatriptan in non-respondent and in adverse drug reaction reporting migraine patients
por: Sternieri, E., et al.
Publicado: (2005)

Cilostazol induced migraine does not respond to sumatriptan in a double blind trial
por: Falkenberg, Katrine, et al.
Publicado: (2018)

To respond or not to respond, the recurring question in plant mechanosensitivity
por: Leblanc-Fournier, Nathalie, et al.
Publicado: (2014)

Chromatin Proteins: Key Responders to Stress
por: Smith, Karen T., et al.
Publicado: (2012)

Eschewing ischemia or responding to it
por: Adler, Elizabeth M.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_m7803013ps44tjpl0gs08opn7h